Abstract: In the drive train of a combustion engine an auxiliary arrangement is arranged which is to be coupled with an axial flow machine including a stator and a rotor, in order to perform an actuating movement. The stator has a coil arrangement, and the rotor has an essentially cup-shaped support for permanent magnet elements. The coil arrangement of the stator has at least one cylindrical winding and is at least partially enclosed by two essentially pot-shaped magnetic flux yokes. Each of the pot-shaped magnetic flux yokes has side areas with magnetic flux poles whose outsides are oriented towards the permanent magnet elements of the rotor. The magnetic flux poles of the stator are arranged spaced apart from the permanent magnet elements of the rotor. The magnetic orientation of neighboring permanent magnet elements towards the air gap alternates.

Abstract: In the drive train of a combustion engine an auxiliary arrangement is arranged which is to be coupled with an axial flow machine comprising a stator and a rotor, in order to perform an actuating movement. The stator has a coil arrangement, and the rotor has an essentially cup-shaped support for permanent magnet elements. The coil arrangement of the stator has at least one cylindrical winding and is at least partially enclosed by two essentially pot-shaped magnetic flux yokes. Each of the pot-shaped magnetic flux yokes has side areas with magnetic flux poles whose outsides are oriented towards the permanent magnet elements of the rotor. The magnetic flux poles of the stator are arranged spaced apart from the permanent magnet elements of the rotor. The magnetic orientation of neighbouring permanent magnet elements towards the air gap alternates.

Abstract: A device for sensing the linear axial displacement of an actuator comprises, in one embodiment, a movable, elongated magnet coupled to the actuator and a fixed Hall sensor. A one-dimensional bearing for the magnet is designed to receive bearing forces in a direction radial to the axial direction by permitting a displacement and pivoting movement of the magnet around the one-dimensional bearing. Arranging the Hall sensor in the region of the one-dimensional bearing ensures that the spacing or gap between the magnet and the Hall sensor remains constant, even in case of a pivoting and/or radial movement of the actuator and of the magnet connected thereto along the full length of displacement of the actuator. Accordingly, the results in sensing the linear displacement of the actuator are not adversely affected by admissible deflections of the actuator from the axial direction of linear displacement.

Abstract: A solenoid plunger system for an electropneumatic pressure transducer, comprising at least partly—in a casing which focuses magnetic field lines M, in particular in the form of an iron casing—a solenoid plunger and a core, in particular in the form of an iron core or magnetic core, wherein the solenoid plunger comprises at least one recess on the side facing towards the core, and/or the core comprises at least one recess on the side facing towards the solenoid plunger, and an air gap is provided between the solenoid plunger and the core; the air gap is adjustable by relative movement between the solenoid plunger and the core, during which relative movement the solenoid plunger can, at least partly, be moved into/out of the first recess in the core, and/or the core can be moved, at least partly, into/out of the recess in the solenoid plunger; the casing comprises at least a first shell and a yoke, each of high magnetic permeability, wherein the first shell is arranged between the solenoid plunger and at least

Abstract: A device for sensing the linear axial displacement of an actuator comprises, in one embodiment, a movable, elongated magnet coupled to the actuator and a fixed Hall sensor. A one-dimensional bearing for the magnet is designed to receive bearing forces in a direction radial to the axial direction by permitting a displacement and pivoting movement of the magnet around the one-dimensional bearing. Arranging the Hall sensor in the region of the one-dimensional bearing ensures that the spacing or gap between the magnet and the Hall sensor remains constant, even in case of a pivoting and/or radial movement of the actuator and of the magnet connected thereto along the full length of displacement of the actuator. Accordingly, the results in sensing the linear displacement of the actuator are not adversely affected by admissible deflections of the actuator from the axial direction of linear displacement.

Abstract: A solenoid plunger system for an electropneumatic pressure transducer, comprising at least partly—in a casing which focuses magnetic field lines M, in particular in the form of an iron casing—a solenoid plunger and a core, in particular in the form of an iron core or magnetic core, wherein the solenoid plunger comprises at least one recess on the side facing towards the core, and/or the core comprises at least one recess on the side facing towards the solenoid plunger, and an air gap is provided between the solenoid plunger and the core; the air gap is adjustable by relative movement between the solenoid plunger and the core, during which relative movement the solenoid plunger can, at least partly, be moved into/out of the first recess in the core, and/or the core can be moved, at least partly, into/out of the recess in the solenoid plunger; the casing comprises at least a first shell and a yoke, each of high magnetic permeability, wherein the first shell is arranged between the solenoid plunger and at least

Abstract: The invention is directed to a solenoid plunger system for an electro-pneumatic pressure transducer comprising at least partially in a cladding, particularly an iron cladding, a solenoid plunger, a core such as an iron core or a magnetic core, at least a first recess in the solenoid plunger and/or a second recess in the core and an air gap between the cladding and the solenoid plunger and/or the core that is adjustable by means of a relative motion between the solenoid plunger and the core while the solenoid plunger is at least partially movable into or, respectively, out of the second recess in the core and/or the core is at least partially movable into or, respectively, out of the first recess in the solenoid plunger, as well as a first damping element in the first recess and/or a second damping element in the second recess.

Abstract: A valve block for at least two valves fixable in a housing having an electric cabling to electrical terminals for the valves and a pneumatic circuit to pneumatic terminals for the valves. The block has an electrical plug connected to the electrical cabling, which extends to the electrical terminals and has a pneumatic plug connected to the pneumatic circuit, which extends to the pneumatic terminals, and the pneumatic circuit proceeds at least partly in a replaceable insert of the housing that can be selected dependent on the valves and/or their function. The pneumatic plug has at least one pneumatic plug connector selectable dependent on the valves and/or their function.

Abstract: The present invention relates to pharmaceutical and cosmetic compositions comprising at least one agonist ligand, which is specific for receptors of the RAR-&ggr; type, which are characterized as inducers of apoptosis in at least one cell population in which apoptosis can be induced by activating receptors of the RAR-&ggr; type. In one aspect of the present invention, there is provided a method of combating photoinduced or chronological ageing of skin, said method comprising administering an effective amount of at least one agonist ligand which is specific for receptors of the RAR-&ggr; type to combat photoinduced or chronological aging of skin, wherein the agonist ligand has a ratio R which is equal to or greater than 10.

Abstract: The invention is directed to a solenoid plunger system for an electro-pneumatic pressure transducer comprising [elements] at least partially [arranged] in a cladding, particularly an iron cladding, [to wit] a solenoid plunger, a core such as an iron core or a magnetic core, at least a first recess in the solenoid plunger and/or a second recess in the core and an air gap between the cladding and the solenoid plunger and/or the core that is adjustable by means of a relative motion between the solenoid plunger and the core while the solenoid plunger is at least partially movable into or, respectively, out of the second recess in the core and/or the core is at least partially movable into or, respectively, out of the first recess in the solenoid plunger, as well as a first damping element in the first recess and/or a second damping element in the second recess.

Abstract: The use of at least one &ggr;-RAR receptor-specific agonist ligand to prepare a pharmaceutical composition for increasing the rate of apoptosis in at least one cell population in which apoptosis may be induced by activating &ggr;-RAR receptors is disclosed. The composition is particularly useful for treating a disease or disorder related to an insufficient rate of apoptosis in at least one cell population in which apoptosis may be induced by activating &ggr;-RAR receptors. The use of at least one &ggr;-RAR receptor-specific agonist ligand as the apoptosis inducer in a cosmetic composition is also disclosed. Said composition may be used to prevent and/or control photo-ageing or chronological ageing of the skin.

Abstract: The invention relates to a valve block for at least two valves, which can be fixed inside a housing (2), comprising: an electric cabling to electric connections for the valves (20a, 20b); a pneumatic cabling to pneumatic connections for the valves; an electric plug (4), out of which the electric cabling to the electric connections extends, and; a pneumatic plug (6a, 6b), out of which the pneumatic cabling to the pneumatic connections extends. The pneumatic cabling runs at least partially inside an interchangeable insert of the housing that can be selected according to the valves and/or their function and/or the pneumatic plug comprises at least one pneumatic plug connection that can be selected according to the valves and/or their function.

Abstract: The present invention relates to the use of at least one RAR receptor agonist ligand, particularly 6-[3-(adamantan-1-yl)-4-(prop-2-ynyloxy)phenyl]naphthalene-2-carboxylic acid or 5-[(E)-3-oxo-3-(5,5,8,8-tetrahydronaphthalene-2-yl)propenyl]thiophene-2-carboxylic acid, to prepare a pharmaceutical composition for increasing the rate of apoptosis in at least one cell population in which apoptosis may be induced by activating RAR-&ggr; receptors. The composition is particularly useful for treating a disease or disorder related to an insufficient rate of apoptosis in at least one cell population in which apoptosis may be induced by activating RAR-&ggr; receptors.

Abstract: Methods of cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of 6-3-(1-adamantyl)-4-hydroxyphenyl)-2-naphthanoic acid.

Abstract: A method for increasing the rate of apoptosis in at least one cell population in which apoptosis is induced by activating receptors of the RAR-&ggr; type, the method comprising exposing the cell population to an effective amount of at least one agonist ligand which is specific for receptors of the RAR-&ggr; type to increase the rate of apoptosis.

Abstract: The differentiation of preadipocytic cells into adipocytic cells, in particular for correcting insulin-resistance disease states in mammalian organisms, notably in humans, for example type II diabetes and cardiovascular disorders such as hypertension and atherosclerosis, is stimulated by treating such preadipocytic cells, or a patient in need of such treatment, with an effective amount of (a) at least one ligand displaying affinity for the nuclear receptors for retinoic acid and/or isomers thereof, preferably at least one ligand displaying a specific affinity for the RAR receptors and even more preferably the RAR-&agr; receptor and (b) at least one fatty acid, e.g., a polyunsaturated fatty acid.

Abstract: The use of a combination of an alpha RAR receptor-specific agonist ligand and a gamma RAR receptor-specific antagonist ligand to reduce the rate of apoptosis is disclosed.

Abstract: The differentiation of preadipocytic cells into adipocytic cells, in particular for correcting insulin-resistance disease states in mammalian organisms, notably in humans, for example type II diabetes and cardiovascular disorders such as hypertension and atherosclerosis, is stimulated by treating such preadipocytic cells, or a patient in need of such treatment, with an effective amount of (a) at least one ligand displaying affinity for the nuclear receptors for retinoic acid and/or isomers thereof, preferably at least one ligand displaying a specific affinity for the RAR receptors and even more preferably the RAR-.alpha. receptor and (b) at least one fatty acid, e.g., a polyunsaturated fatty acid.

Abstract: The differentiation of preadipocytic cells into adipocytic cells, in particular for correcting insulin-resistance disease states in mammalian organisms, notably in humans, for example type II diabetes and cardiovascular disorders such as hypertension and atherosclerosis, is stimulated by treating such preadipocytic cells, or a patient in need of such treatment, with an effective amount of (a) at least one ligand displaying affinity for the nuclear receptors for retinoic acid and/or isomers thereof, preferably at least one ligand displaying a specific affinity for the RAR receptors and even more preferably the RAR-.alpha. receptor and (b) at least one fatty acid, e.g., a polyunsaturated fatty acid.

Abstract: The differentiation of preadipocytic cells into adipocytic cells, in particular for correcting insulin-resistance disease states in mammalian organisms, notably in humans, for example type II diabetes and cardiovascular disorders such as hypertension and atherosclerosis, is stimulated by treating such preadipocytic cells, or a patient in need of such treatment, with an effective amount of (a) at least one ligand displaying affinity for the nuclear receptors for retinoic acid and/or isomers thereof, preferably at least one ligand displaying a specific affinity for the RAR receptors and even more preferably the RAR-.alpha. receptor and (b) at least one fatty acid, e.g., a polyunsaturated fatty acid.